A Randomized Clinical Trial on the Effect of Guided Imagery and Progressive Muscle Relaxation for the Management of Pain, Stress, Anxiety and Depression as a Means to Improve the Psychological Well-being and the Quality of Life for Patients With Breast and Prostate Cancer
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Breast Cancer
- Sponsor
- Cyprus University of Technology
- Enrollment
- 200
- Locations
- 1
- Primary Endpoint
- Stress
- Status
- Completed
- Last Updated
- 14 years ago
Overview
Brief Summary
The purpose of this study is to determine whether Guided Imagery and Progressive Muscle Relaxation techniques are effective in the management of pain, fatigue, nausea-vomit, anxiety and depression in patients with either prostate or breast cancer.
This study includes a total of 200 patients with prostate and breast cancer randomly assigned to either a control or intervention group.
The intervention group received in total 4 sessions of Guided Imagery (protocol floating on a cloud) and Progressive Muscle Relaxation (breathing exercises and use of 11 groups of muscle progressively tensing and relaxing).
Measurements included the assessment of pain, fatigue, nausea-vomit, depression, anxiety and quality of life. Additionally, saliva samples were collected prior and after the sessions as to assess saliva cortisol and saliva α-amylase.
The same measurements were received by the patients of the control group as to allow comparisons.
Investigators
Dr. Andreas Charalambous
Lecturer-Researcher
Cyprus University of Technology
Eligibility Criteria
Inclusion Criteria
- •Clinical diagnosis of breast or prostate cancer
- •Must be able to follow instructions
- •Good cognitive ability
- •Willing to participate
Exclusion Criteria
- •Use of cortisone
- •Xerostomia
- •oral mucositis
Outcomes
Primary Outcomes
Stress
Time Frame: 20 months
Saliva α-amylase and saliva cortisol
Secondary Outcomes
- Depression(20 months)
- Nausea-vomit(20 months)
- Pain(20 months)
- Fatigue(20 months)
- Anxiety(20 months)
- Quality of Life(20 months)